Compare VIR & RMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | RMIX |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2019 | 2026 |
| Metric | VIR | RMIX |
|---|---|---|
| Price | $11.31 | $17.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.43 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 253.4K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $68,556,000.00 | N/A |
| Revenue This Year | $270.22 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.75 | $16.59 |
| 52 Week High | $11.66 | $25.50 |
| Indicator | VIR | RMIX |
|---|---|---|
| Relative Strength Index (RSI) | 73.93 | 44.82 |
| Support Level | $8.43 | $17.00 |
| Resistance Level | $11.66 | $18.81 |
| Average True Range (ATR) | 0.51 | 1.03 |
| MACD | 0.25 | 0.03 |
| Stochastic Oscillator | 93.86 | 29.17 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Suncrete Inc is a ready-mix concrete logistics and distribution platform operating across Oklahoma and Arkansas. Ready-mix concrete is a crucial building material that is used in the vast majority of infrastructure, commercial and residential construction projects. The company's ready-mix concrete business engages principally in the precise formulation, efficient production and on-time delivery of ready-mix concrete to the customers' job sites. It serves substantially all end markets of the construction industry in the select geographic markets. The company earns revenue prominently from the production and delivery of ready-mix concrete, with the majority revenue generated from orders under master purchase agreements or through direct sales to third-party contractors and suppliers.